Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Scheinberg

Showing results (411-420 of 426) with videos related to

Pageof 43
Sort By:
Journal of the National Cancer Institute|May 14, 2010
Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growthOlaf Penack, Erik Henke, David Suh, et al.
Theranostics|October 14, 2020
Alpha radioimmunotherapy using <sup>225</sup>Ac-proteus-DOTA for solid tumors - safety at curative dosesSarah M Cheal, Michael R McDevitt, Brian H Santich, et al.
Nature Medicine|April 28, 2022
Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CASmita S Chandran, Jiaqi Ma, Martin G Klatt, et al.
The Lancet. Rheumatology|January 27, 2024
Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trialSaira Z Sheikh, Morton A Scheinberg, James Cheng-Chung Wei, et al.
Cancer Discovery|January 10, 2020
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in LymphomaPatrizia Mondello, Saber Tadros, Matt Teater, et al.
Plos Pathogens|January 8, 2024
Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIPAyana E Morales, Ruby Gumenick, Caitlyn M Genovese, et al.
Genome Biology|November 19, 2016
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signaturesYasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
Genome Biology|March 3, 2017
Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signaturesYasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
Blood|August 27, 2025
CD371-Targeted CAR T cells Secreting Interleukin-18 Exhibit Robust Expansion and Clear Refractory Acute Myeloid LeukemiaMark B Geyer, Susan DeWolf, Xiaoli Mi, et al.
Nature Nanotechnology|March 12, 2020
Banning carbon nanotubes would be scientifically unjustified and damaging to innovationDaniel A Heller, Prakrit V Jena, Matteo Pasquali, et al.
Pageof 43

Showing results (411-420 of 426) with videos related to

Sort By:
Pageof 43
Journal of the National Cancer Institute|May 14, 2010
Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growthOlaf Penack, Erik Henke, David Suh, et al.
Theranostics|October 14, 2020
Alpha radioimmunotherapy using <sup>225</sup>Ac-proteus-DOTA for solid tumors - safety at curative dosesSarah M Cheal, Michael R McDevitt, Brian H Santich, et al.
Nature Medicine|April 28, 2022
Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CASmita S Chandran, Jiaqi Ma, Martin G Klatt, et al.
The Lancet. Rheumatology|January 27, 2024
Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trialSaira Z Sheikh, Morton A Scheinberg, James Cheng-Chung Wei, et al.
Cancer Discovery|January 10, 2020
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in LymphomaPatrizia Mondello, Saber Tadros, Matt Teater, et al.
Plos Pathogens|January 8, 2024
Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIPAyana E Morales, Ruby Gumenick, Caitlyn M Genovese, et al.
Genome Biology|November 19, 2016
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signaturesYasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
Genome Biology|March 3, 2017
Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signaturesYasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
Blood|August 27, 2025
CD371-Targeted CAR T cells Secreting Interleukin-18 Exhibit Robust Expansion and Clear Refractory Acute Myeloid LeukemiaMark B Geyer, Susan DeWolf, Xiaoli Mi, et al.
Nature Nanotechnology|March 12, 2020
Banning carbon nanotubes would be scientifically unjustified and damaging to innovationDaniel A Heller, Prakrit V Jena, Matteo Pasquali, et al.
Pageof 43